Seasonal influenza vaccination: Overcoming immunosenescence with enhanced vaccines
Influenza causes substantial morbidity and mortality worldwide. Risks are increased in older adults aged 50–64 and ≥ 65 years. They are further exacerbated in those with age-related comorbidities. Immunosenescence (strictly defined here as detrimental age-related decline in the function of some or a...
Saved in:
| Main Authors: | Wendy Boivin, Mark Loeb, Peter Openshaw, Mansoor Ashraf, Graham Pawelec |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-06-01
|
| Series: | Vaccine: X |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136225000567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Seasonal Inactivated Influenza Vaccines Prophylactic Efficacy
by: K. V. Zhdanov, et al.
Published: (2022-11-01) -
Early and Late Influenza Vaccine Effectiveness in South Korea During the 2023–2024 Season
by: Yu Jung Choi, et al.
Published: (2025-02-01) -
Seasonal influenza vaccines: Variability of immune responses to B lineage viruses
by: Matthew S. Miller, et al.
Published: (2024-12-01) -
Age-related changes in the immune system and challenges for the development of age-specific vaccines
by: T. Mark Doherty, et al.
Published: (2025-12-01) -
Cost-Effectiveness of Adjuvanted Influenza Vaccine Compared with Standard and High-Dose Influenza Vaccines for Persons Aged ≥50 Years in Spain
by: Alberto Perez-Rubio, et al.
Published: (2025-03-01)